- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 56.41M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 56.67M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 56.56M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $4.71M |
| Capex | Q1 2026 · Mar 31, 2025 | $3.56M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $28.3M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $15.01M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $546.59M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $542.21M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $582.65M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $566.02M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $697.23M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $2.11B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $2.11B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $1.99B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $1.97B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $126.21M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $135.83M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $825.31M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $843.57M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.16B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.14B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $2.93B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $2.95B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.15 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.10 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.15 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.10 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $76.54M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $70.71M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $14.46M |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $12.11M |
| Net Income | Q1 2026 · Mar 31, 2026 | $8.33M |
| Net Income | Q1 2026 · Mar 31, 2025 | $5.83M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $15.94M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $6.58M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $85.97M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $77.8M |